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Introduction 
Reversible airway obstruction is a characteristic 
feature of asthma (1). On a pathophysiological basis 
this is produced by bronchoconstriction, mucosal 
oedema and inspissated secretions (2). Modern drug 
therapy for asthma is directed towards controlling 
mucosal inflammation and hence reversing broncho- 
constriction and mucosal oedema (3). However, 
during acute exacerbations, sputum plugging may 
contribute significantly to the pathophysiology of 
asthma and this may be more difficult to treat. 
The possible role of intensive humidification to 
liquefy inspissated secretions, in conjunction with 
physiotherapy to mobilize these secretions, has 
received little recent attention in the management of 
asthma. We report four cases of acute asthma which 
failed to reverse fully until intensive humidification of 
their respiratory tract was achieved. We used an 
ultra-Neb 99 ultrasonic nebulizer (De Vilbiss Health 
Care U.K. Ltd, Heston, Middx, U.K.) adjusted to 
produce an aerosol output of 3 ml min-‘, particle 
size being 0.5-5pm. Sterile 0.9% sodium chloride 
warmed to room temperature was used in all 
instances. In all cases humidification was combined 
with regular physiotherapy to clear the increased 
volume of secretions. All patients had been receiving 
regular physiotherapy as part of standard treatment 
prior to the introduction of intensive humidification. 
Case Reports 
CASE 1 
A 39-year-old woman, a non-smoker with asthma 
since childhood, presented with an acute severe 
attack precipitated by an upper respiratory tract 
infection. On admission she was too breathless to 
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talk, centrally cyanosed and mildly pyrexial(37.8”C). 
Her pulse was 120 beats/min, pulsus paradoxus was 
present (15 mmHg), peak expiratory flow rate 
(PEFR) was unrecordable and PaO, and PaCO, on 
40% 0, by face mask were 7.4 kPa and 3.7 kPa 
respectively. Physical and radiological examination 
revealed collapse of the left lower lobe. She was 
treated intensively with nebulized and intravenous 
bronchodilators, intravenous and oral glucocortico- 
steroids and intravenous antibiotics. She made good 
initial progress over the first few days, PEFR rising to 
200 1 min ~ I, but thereafter failed to improve further. 
Chest X-ray confirmed persisting left lower lobe 
collapse (Plate 1). This did not respond to routine 
humidification or to physiotherapy. She was there- 
fore treated with inhaled normal saline produced by 
an ultrasonic nebulizer. After a test dose to exclude 
aerosol-induced bronchoconstriction, she was 
encouraged to inhale the ultrasonically produced 
normal saline via a mouthpiece for as much of each 
day as was possible. During this time she received 
regular physiotherapy. Over the next 48 h she pro- 
duced a large quantity of thick green sputum, her 
breathlessness improved and her PEFR rose to 
340 1 min- ’ and her chest X-ray returned to normal. 
Investigations revealed no eosinophilia and an 
absence of precipitating antibodies for Aspergillus 
fumigatus. 
C.SB 2 
A 21-year-old man with lifelong asthma was 
admitted with an infective exacerbation. He was 
apyrexial but producing a small amount of green 
sputum. There was no tachycardia or pulsus para- 
doxus, but he had diffuse loud expiratory wheezes 
and his PEFR was reduced from his normal value of 
550-660 to 220 1 min- ‘. Arterial blood gases breath- 
ing room air revealed a PaO, of 5.2 kPa. Chest X-ray 
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&. 1 Chest radiograph of patient 1 showing (a) left lower lobe collapse and (b) re-expansion of the left lower lobe after 
treatment with ultrasonically~nebulized normal saline. 
showed left lower lobe collapse. In the past he had 
required bronchoscopy to clear inspissated secretions 
producing right upper lobe collapse. There was no 
eosinophilia and Aspergillus fimigatus precipitins 
were absent. Despite intravenous antibiotics, maxi- 
mal oral and parenteral treatment of his asthma, and 
physiotherapy he failed to fully recover having made 
initial progress over the first 2 days. His PEFR 
remained at 380450 1 min- ‘. After a test dose of 
ultrasonically nebulized normal saline to exclude 
aerosol-induced bronchoconstriction, he was treated 
with this for several hours each day. Regular chest 
physiotherapy was continued. Over the next 48 h he 
expectorated a large quantity of sputum and his 
PEFR rose to over 600 1 min- ‘. His left lower lobe 
collapse resolved radiologically. 
CASE 3 
An so-year-old non-smoker with a 30-year history 
of asthma was admitted with a 3-week history of 
worsening breathlessness. She was mildly pyrexial, 
had a tachycardia of 110 beatslmin, 20 mmHg of 
pulsus paradoxus and loud expiratory wheezes. Her 
PEFR was 60 1 min- ‘, and her chest X-ray did not 
reveal any focal lesion. Her PaO, and PaCO, on 40% 
inhaled oxygen were 14 kPa and 8.5 kPa respectively. 
She was treated with broad spectrum intravenous 
antibiotics, maximal oral and parenteral broncho- 
dilators and glucocorticosteroids and physiotherapy. 
Despite these measures, she remained breathless and 
wheezy. She subsequently complained of difficulty 
expectorating her sputum and was treated with ultra- 
sonically nebulized normal saline. This resulted in 
moderate sputum production and considerable 
improvement over the next 72 h, her PEFR rising to 
200 1 min-‘. 
CASE 4 
A 59-year-old man with longstanding atopic 
asthma, was admitted with an infective exacerbation 
which had failed to respond to oral antibiotics and 
glucocorticosteroids as an outpatient. He was dys- 
pnoeic at rest, apyrexial, his pulse was 100 min-’ 
there was no pulsus paradoxus, loud inspiratory and 
expiratory wheezes were present and his PEFR was 
lOOlmin- ’ (best 360 1 min- ‘). Arterial blood gases 
breathing room air showed a PaO, of 9.7 kPa and a 
PaCO, of 4.4 kPa. There was no focal lesion on the 
chest X-ray. His antibiotic was changed, the dose of 
oral prednisolone was increased, and he was treated 
with nebulized bronchodilators and received physio- 
therapy. Despite an initial response to these mea- 
sures, he failed to improve further. He was therefore 
treated with ultrasonically nebulized normal saline. 
After 24 h he was able to expectorate several plugs of 
sputum and thereafter a considerable volume of 
infected sputum. His clinical status consequently 
improved, his PEFR rising to 325 1 min-r, and he 
made a full recovery. 
Discussion 
In these four cases full resolution of the acute 
asthmatic attack was not achieved until the introduc- 
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tion of therapy aimed at liquefying and mobilizing 
inspissated secretions. In two cases (1 and 2) the site 
of sputum retention was most significant in the left 
lower lobe, whereas in the other two instances there 
was no evidence of a localized effect, and its was 
presumed that there was widespread and diffuse 
peripheral involvement. Nevertheless, the failure of 
these last two cases (3 and 4) to fully respond until 
the introduction of humidification and physio- 
therapy, and the occurrence of resolution pavi passu 
with the production of a large volume of sputum, is 
putative evidence that there was indeed widespread 
obstruction of peripheral airways by inspissated 
secretions. 
Certain aspects of the use of ultrasonically nebu- 
lized solutions for humidification deserve emphasis. 
We were careful to use only normal saline in view 
of the proven ability of hypo and hypertonic solu- 
tions to elicit bronchoconstriction in asthmatic sub- 
jects (4) and we did not use cooled solutions since 
ultrasonic nebulizers produce mist at ambient tem- 
perature and cold solutions might have provoked 
further airways narrowing. In addition, subjects 
were carefully observed during the initiation of 
therapy to ensure that it did not produce any 
deterioration in their condition and humidification 
was always used in conjunction with physiotherapy 
to mobilize the liquefied secretions, in view of the 
possibility that the increased volume of secretions 
might otherwise accumulate and increase airways 
obstruction (5). Finally, since at high volume out- 
puts (3-6 ml min-‘) it is possible that the dense 
aerosol generated by ultrasonic devices might 
increase the work of breathing, we used an output 
of <3 ml min-‘. 
This study has not compared humidification by 
ultrasonic nebulizer with humidification by jet 
nebulizer which may be just as effective. The only 
difference between the two is the 2-10 fold greater 
output delivered by ultrasonic devices, due largely to 
the larger particle size produced by them (5-7,~~rn 
volume median aerodynamic diameter compared 
with 2-3,~m). This may affect the site of particle 
deposition. 
The increased sputum clearance produced by 
humidification is probably due to a number of fac- 
tors. Humidification may alter the depth and viscos- 
ity of the periciliary layer to more optimum values (6) 
and it may increase the efficiency of the forced 
expiration technique (FET) used in physiotherapy, 
and of the cough mechanism. It may also improve the 
facility with which sputum can be ‘sheared’ from the 
airway wall by the FET or by cough. 
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